The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of type 2 diabetes mellitus in adults and children aged 10 years and above, and heart failure and chronic kidney disease in adults patiens.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522976-10-00

Acronym

1046/25

Enrollment

Registered

2025-08-19

Start date

2025-09-10

Completion date

2025-11-24

Last updated

2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not applicable (submitted trial is a BE study in healthy subjects.

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Czechia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026